safety and immunogenicity of a fully liquid vaccine containing five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-haemophilus influenzae type b conjugate vaccines administered at two, four, six and 18 months of age
Clics: 383
ID: 194788
2007
Métriques de Qualité et de Performance de l'Article
Qualité Globale
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Engagement des Lecteurs
Popular Article
30.0
/100
383 vues
39 lecteurs
Évaluation de la Qualité par IA
Non analysé
Readership in this journal
PopularRanked #4 of 94 articles by views in zdravstveno varstvo
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Résumé
OBJECTIVE: The safety, immunogenicity and lot consistency of a fully liquid, five-component acellular pertussis combination vaccine, comprised of diphteria, tetanus and acellular pertussis, inactivated polio vaccine, Haemophilus influenzae type b (DTaP-IPV-Hib [Pediacel, sanofi pasteur, Canada]) were assessed and compared with that of Hib vaccine reconstituted with the five-component acellular pertussis combination vaccine (DTaP-IPV//Hib, Pentacel [sanofi pasteur, Canada]).
| Clé de Référence |
gold2007canadiansafety
Utilisez cette clé pour citer automatiquement dans le manuscrit lors de l'utilisation de
SciMatic Manuscript Manager ou Thesis Manager
|
|---|---|
| Auteurs | ;Ronald Gold;Luis Barreto;Santiago Ferro;John Thippawong;Roland Guasparini;William Meekison;Margaret Russell;Elaine Mills;Dana Harrison;Pierre Lavigne |
| Revue | zdravstveno varstvo |
| Année | 2007 |
| DOI |
10.1155/2007/289842
|
| URL | |
| Mots-clés |
Citations
Aucune citation trouvée. Pour ajouter une citation, contactez l'administrateur à info@scimatic.org
Commentaires
Aucun commentaire pour le moment. Soyez le premier à commenter cet article.